The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorChina Medical University Hospital
About this trial
Critically ill patients are at risk of or suffering from one or more key organs or organ system failure. This study will measure the effect of traditional Chinese medicine(TCM) interventions on critically ill patients admitted to the intensive care unit (ICU).
The goal of this clinical trial is to learn if traditional Chinese medicine(TCM) is effective for prevention and treatment of organ failure in ICU patients. Patients in this group will receive intervention for 2 weeks.
A multi-center non-randomized real word data study, will include 3 groups: intervention group (TCM)(n=70), control group and historical control group (admitted to the same ICU in the period of 01.2019 to 12.2023).
Main outcomes include sequential organ failure assessment (SOFA) score, ICU length of stay, hospital length of stay, number of days of respirator uses and western medicine medication used study follow up will be 2 weeks.
Eligibility criteria
Qualifiers
Age 20 and above
Surgical ICU patients
The use of Chinese medicine must be approved by the attending physician in the surgical intensive care unit
Disqualifiers
Patients' family members refuse TCM intervention
Trial design
Treatments tested in this trial
- traditional Chinese medicine
- Routine ICU care
- historical Routine ICU care
Treatment groups
350 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov